参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/12/06 | 1,762 | 1,786 | 1,758 | 1,762 | -13 | -0.7% | 1,033,200 |
2017/12/05 | 1,760 | 1,788 | 1,750 | 1,775 | +25 | +1.4% | 1,294,800 |
2017/12/04 | 1,760 | 1,774 | 1,746 | 1,750 | +18 | +1% | 2,606,200 |
2017/12/01 | 1,740 | 1,749 | 1,719 | 1,732 | +20 | +1.2% | 1,597,500 |
2017/11/30 | 1,689 | 1,719 | 1,682 | 1,712 | -14 | -0.8% | 2,552,000 |
2017/11/29 | 1,691 | 1,727 | 1,686 | 1,726 | +41 | +2.4% | 1,350,800 |
2017/11/28 | 1,667 | 1,688 | 1,658 | 1,685 | +34 | +2.1% | 1,585,500 |
2017/11/27 | 1,630 | 1,654 | 1,612 | 1,651 | -59 | -3.5% | 2,053,000 |
2017/11/24 | 1,696 | 1,715 | 1,672 | 1,710 | +7 | +0.4% | 1,745,400 |
2017/11/22 | 1,772 | 1,777 | 1,701 | 1,703 | -73 | -4.1% | 1,656,400 |
2017/11/21 | 1,771 | 1,785 | 1,764 | 1,776 | +5 | +0.3% | 1,094,500 |
2017/11/20 | 1,789 | 1,805 | 1,765 | 1,771 | -21 | -1.2% | 1,350,900 |
2017/11/17 | 1,799 | 1,809 | 1,775 | 1,792 | +10 | +0.6% | 1,628,100 |
2017/11/16 | 1,741 | 1,789 | 1,734 | 1,782 | +52 | +3% | 1,236,100 |
2017/11/15 | 1,732 | 1,748 | 1,726 | 1,730 | -14 | -0.8% | 967,800 |
2017/11/14 | 1,744 | 1,759 | 1,736 | 1,744 | -9 | -0.5% | 886,200 |
2017/11/13 | 1,766 | 1,766 | 1,751 | 1,753 | -22 | -1.2% | 874,900 |
2017/11/10 | 1,759 | 1,778 | 1,752 | 1,775 | -11 | -0.6% | 1,044,800 |
2017/11/09 | 1,780 | 1,810 | 1,770 | 1,786 | +17 | +1% | 1,440,100 |
2017/11/08 | 1,753 | 1,769 | 1,749 | 1,769 | +12 | +0.7% | 822,800 |
2017/11/07 | 1,744 | 1,757 | 1,726 | 1,757 | +4 | +0.2% | 1,128,800 |
2017/11/06 | 1,749 | 1,754 | 1,723 | 1,753 | -10 | -0.6% | 1,236,400 |
2017/11/02 | 1,800 | 1,800 | 1,754 | 1,763 | -40 | -2.2% | 1,391,900 |
2017/11/01 | 1,810 | 1,810 | 1,791 | 1,803 | +4 | +0.2% | 1,308,300 |
2017/10/31 | 1,796 | 1,805 | 1,782 | 1,799 | -1 | -0.1% | 789,000 |
2017/10/30 | 1,800 | 1,805 | 1,778 | 1,800 | -34 | -1.9% | 1,800,300 |
2017/10/27 | 1,800 | 1,836 | 1,791 | 1,834 | +30 | +1.7% | 1,061,700 |
2017/10/26 | 1,818 | 1,826 | 1,793 | 1,804 | -14 | -0.8% | 855,600 |
2017/10/25 | 1,830 | 1,832 | 1,813 | 1,818 | -14 | -0.8% | 1,219,200 |
2017/10/24 | 1,820 | 1,835 | 1,814 | 1,832 | +6 | +0.3% | 979,200 |
2017/10/23 | 1,837 | 1,837 | 1,822 | 1,826 | -9 | -0.5% | 1,659,700 |
2017/10/20 | 1,828 | 1,837 | 1,822 | 1,835 | ±0 | ±0% | 1,167,800 |
2017/10/19 | 1,813 | 1,838 | 1,804 | 1,835 | +14 | +0.8% | 1,202,300 |
2017/10/18 | 1,782 | 1,823 | 1,782 | 1,821 | +53 | +3% | 1,024,700 |
2017/10/17 | 1,776 | 1,793 | 1,765 | 1,768 | +2 | +0.1% | 1,235,700 |
2017/10/16 | 1,766 | 1,801 | 1,762 | 1,766 | ±0 | ±0% | 2,064,900 |
2017/10/13 | 1,760 | 1,777 | 1,753 | 1,766 | +8 | +0.5% | 2,001,000 |
2017/10/12 | 1,749 | 1,762 | 1,742 | 1,758 | +4 | +0.2% | 1,024,000 |
2017/10/11 | 1,748 | 1,761 | 1,746 | 1,754 | +4 | +0.2% | 782,100 |
2017/10/10 | 1,732 | 1,750 | 1,728 | 1,750 | +5 | +0.3% | 675,700 |
2017/10/06 | 1,768 | 1,770 | 1,742 | 1,745 | -23 | -1.3% | 648,000 |
2017/10/05 | 1,773 | 1,780 | 1,762 | 1,768 | +6 | +0.3% | 722,600 |
2017/10/04 | 1,787 | 1,795 | 1,755 | 1,762 | -25 | -1.4% | 888,100 |
2017/10/03 | 1,765 | 1,790 | 1,755 | 1,787 | +44 | +2.5% | 1,233,700 |
2017/10/02 | 1,774 | 1,774 | 1,737 | 1,743 | -30 | -1.7% | 1,314,200 |
2017/09/29 | 1,754 | 1,776 | 1,749 | 1,773 | +21 | +1.2% | 1,072,600 |
2017/09/28 | 1,737 | 1,753 | 1,721 | 1,752 | +10 | +0.6% | 1,116,500 |
2017/09/27 | 1,753 | 1,760 | 1,733 | 1,742 | -22 | -1.2% | 2,029,800 |
2017/09/26 | 1,765 | 1,777 | 1,753 | 1,764 | +5 | +0.3% | 1,121,000 |
2017/09/25 | 1,752 | 1,764 | 1,737 | 1,759 | +10 | +0.6% | 1,534,600 |
1701~
1750
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム